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Abstract
Background: Bacillus organisms are common laboratory contaminants. The majority of Bacillus
bacteraemias are transient and not clinically significant. Clinically significant infection due to Bacillus
species is rare and mostly due to Bacillus cereus infections in immuno-compromised hosts.
Case presentation: We report a case of central venous catheter infection with Bacillus pumilus
in an immunocompetent child with tufting enteropathy on long-term parenteral nutrition (PN).
There were three episodes of central venous catheter infection with Bacillus pumilus in three
months. Despite adequate and appropriate use of intravenous antibiotics, the infection failed to
clear resulting in the need for removal of the catheter for complete cure.
Conclusion: Bacillus species can cause clinically significant central venous catheter infection, even
in an immunocompetent host. Despite adequate antibiotic treatment, the central venous catheter
may need removal for complete cure.
Background
Central venous catheter infections are a major cause of
morbidity [1-3]. In most cases, the offending organisms
are coagulase-negative staphylococci, Staphylococcus
aureus, gram-negative bacilli, and Candida species.
Bacillus species are common contaminants of blood cul-
tures but clinically significant infection is rare [4,5]. Sig-
nificant central venous catheter infections caused by
Bacillus species are mainly due to B cereus and have
mostly been reported in immunocompromised hosts
[6,7]. We report a case of central venous catheter infection
with Bacillus pumilus, in an immunocompetent child
with tufting enteropathy on long-term parenteral nutri-
tion.
Case report
An 8 year old girl with tufting enteropathy on long-term
parenteral nutrition presented on 3 occasions with central
venous catheter infection due to Bacillus species. On each
occasion, she had fever after flushing of the central venous
catheter. She had initially presented in the first few
months of life with chronic watery diarrhoea and
impaired growth, and was found to have tufting enterop-
athy (intestinal epithelial dysplasia) [8]. This is a rare con-
genital enteropathy, which requires indefinite
dependence on parenteral nutrition from early infancy.
The child is on regular parenteral nutrition and has had
no previous history of significant infections, except for
central venous catheter infections with coagulase negative
staphylococci. Immunoglobulins, neutrophil and lym-
Published: 29 October 2007
Annals of Clinical Microbiology and Antimicrobials 2007, 6:12 doi:10.1186/1476-0711-6-
12
Received: 12 July 2007
Accepted: 29 October 2007
This article is available from: http://www.ann-clinmicrob.com/content/6/1/12
© 2007 Bentur et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Annals of Clinical Microbiology and Antimicrobials 2007, 6:12 http://www.ann-clinmicrob.com/content/6/1/12
Page 2 of 3
(page number not for citation purposes)
phocyte counts were within the normal range. There was
no history of significant trauma, injuries or skin infections
prior to this episode, except a small cut on her finger
which healed very well and was generally well in herself.
She lives with her parents and is well cared for. There is no
history of contact with plant growth products or animal
probiotics at any time.
First episode
The child presented with fever and rigors to her local hos-
pital. Bacillus species was isolated from blood taken from
the central venous catheter, which was reported sensitive
to flucloxacillin. She was treated with 4 weeks of intrave-
nous flucloxacillin because bacteraemia had persisted
despite 14 days of treatment.
Second episode
The child was transferred to our hospital with recurrence
of fever and rigors, 10 days after stopping the antibiotics.
Empirical treatment was started with intravenous cefotax-
ime and flucloxacillin. Bacillus species was isolated from
central venous catheter cultures both before and whilst on
cefotaxime and flucloxacillin. This was later identified as
Bacillus pumilus at the National Reference Laboratory
(Health Protection Agency, Centre For Infection, Lon-
don). The methods used to identify the organism were
gram stain to determine whether spores are produced,
short biochemical profile based on ammonia salt sugars,
Lecithinase and mannitol (B. pumilus is lecithinase nega-
tive and mannitol positive) and DNA sequencing. B
pumilus was reported to be sensitive to vancomycin and
erythromycin. There were concerns that the patient had
previously reacted to systemic vancomycin, so antibiotics
were changed to intravenous clindamycin with vancomy-
cin line locks given for 2 weeks. Blood cultures, taken both
during and after this treatment, were negative. Echocardi-
ography showed no evidence of vegetations at the tip of
the catheter or in the heart.
Third episode
Ten days after stopping the intravenous antibiotics the
child presented for the third time with fever and rigors. A
Bacillus species was again grown from blood taken from
the central venous catheter. The central venous catheter
was removed after 5 days treatment with intravenous van-
comycin and a new central venous catheter was inserted.
Subsequent blood cultures were negative and there has
been no recurrence of further fever or infections over a 9-
month period, suggesting the infection has been eradi-
cated.
Discussion
Central Venous Catheter infection is an important cause
of morbidity in children dependent upon central venous
catheters. In about two-thirds of cases, the offending
organisms are coagulase-negative staphylococci, Staphy-
lococcus aureus and gram negative bacilli. Candida spe-
cies are responsible for one-third of these infections and
carry a worse prognosis [1-3]. Currently there are no pub-
lished data on the frequency with which Bacillus species
are recovered from central venous catheters, but clinically
significant infection due to Bacillus species are rare.
Most reports of infections caused by Bacillus species have
occurred in intravenous drug users, those with prosthetic
valvular devices and in immuno-compromised hosts [9].
Bacillus species grown from blood are frequently assumed
to be contaminants. Bacillus species are isolated from
0.1–0.9% of blood cultures, but only 5–10% of these are
clinically significant infections [4,5]. Since Bacillus iso-
lates are frequently dismissed as contaminants most labo-
ratories do not identify these isolates further. Infection
due to Bacillus pumilus has thus been rarely reported.
The genus Bacillus consists of a heterogenic group of
gram-positive, endospore-forming, rod-shaped, faculta-
tive anaerobic bacteria [10]. Bacillus species other than
Bacillus anthracis produce spores that are widespread in
the environment, and isolation from a specimen may rep-
resent contamination. Of the non-anthrax Bacillus spe-
cies, B. cereus, B. licheniformis, and B. pumilus may be
more pathogenic in immunosuppressed hosts than other
common Bacillus species, (B. subtilis or B. megaterium).
However, Bacillus pumilus has rarely been reported as a
human pathogen.
Risk factors for Bacillus bacteraemia include intravenous
drug use [9] hemodialysis [11] and leukemia [12]. Intra-
vascular catheters, pacemaker wires, skin or wound infec-
tions have all been reported as potential portals of entry
of infection for bacteraemia with Bacillus [6,7]. Signifi-
cant bacteraemia with Bacillus species has been described
in immunosuppressed or cancer patients [[11-13] and
[14]]. To our knowledge, there is one case report of Bacil-
lus cereus infection of a central line in an immunocompe-
tent patient (a child with haemophilia) [15]. It is unclear
why our patient should have infection with Bacillus
pumilus, although there may be some subtle immune
dysfunction in tufting enteropathy in addition to malab-
sorption [8].
Bacillus pumilus has toxic properties; it has cytopathic
effects in Vero cells, haemolytic activity, lecithinase pro-
duction, and proteolytic action on casein [16,17]. The
organism produces a toxin that has been detected in
guinea pigs with experimentally induced enterocolitis
associated with clindamycin [13]. Bacillus pumilus is also
known to be used in some plant growth products [18] and
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Antibiotics, which appear useful in the treatment of non
cereus Bacillus, are clindamycin, imipenem, ciprofloxacin
and vancomycin, to which the vast majority of strains are
susceptible [20,21]. Some suggest that initial antibiotic
treatment should be vancomycin until susceptibilities are
known. We did not use this initially in our case because of
concerns about a possible previous reaction to vancomy-
cin. However despite an adequate course of appropriate
antibiotics the infection recurred as in previous reports of
Bacillus central venous catheter infection [3]. Guidelines
are not available for antibiotic testing of Bacillus species
by routine disc susceptibility testing [22]. Tests to deter-
mine minimum inhibitory concentrations are therefore
needed.
Central venous catheter infection with some organisms
(e.g. coagulase negative staphylococci), can be success-
fully eradicated by antibiotics alone without resorting to
catheter removal [3]. However, central venous catheter
infection with Bacillus species usually requires catheter
removal for complete cure, as in our case [1-3].
Our experience suggests that Bacillus species can cause
clinically significant central venous catheter infections,
even in an immunocompetent child. Bacillus species iso-
lated from blood taken from central venous catheters
should not be dismissed as contaminants; instead more
blood cultures should be taken. Treatment should be
instituted if these repeat cultures are positive or if the
patient's deteriorates clinically. However, despite antibi-
otic treatment the central venous catheter may need
removal for complete cure.
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